Christopher Carter

18.1k total citations · 3 hit papers
141 papers, 10.8k citations indexed

About

Christopher Carter is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Christopher Carter has authored 141 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 51 papers in Cellular and Molecular Neuroscience and 15 papers in Surgery. Recurrent topics in Christopher Carter's work include Neuroscience and Neuropharmacology Research (32 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Ion channel regulation and function (16 papers). Christopher Carter is often cited by papers focused on Neuroscience and Neuropharmacology Research (32 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Ion channel regulation and function (16 papers). Christopher Carter collaborates with scholars based in United Kingdom, United States and France. Christopher Carter's co-authors include C Pycock, B. Scatton, Robert Kerwin, Timothy B. Lowinger, Brian Schwartz, Roger A. Smith, Jacques Dumas, Susan L. Kelley, Mark Lynch and Scott M. Wilhelm and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Christopher Carter

137 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer

2006 1.4k citations Scott M. Wilhelm, Christopher Carter et al. Nature Reviews Drug Discovery profile →
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

1989 1.1k citations David T. Dexter, Christopher Carter et al. Journal of Neurochemistry profile →
Pulmonary Angiography, Ventilation Lung Scanning, and Venography for Clinically Suspected Pulmonary Embolism with Abnormal Perfusion Lung Scan

1983 464 citations Christopher Carter et al. profile →

Peers

Countries citing papers authored by Christopher Carter

Since Specialization

Citations

This map shows the geographic impact of Christopher Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Carter more than expected).

Fields of papers citing papers by Christopher Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Carter. The network helps show where Christopher Carter may publish in the future.

Co-authorship network of co-authors of Christopher Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Carter. A scholar is included among the top collaborators of Christopher Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Carter. Christopher Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease 2017 ·Journal of Alzheimer s Disease Reports ·Christopher Carter	50
2	The Porphyromonas gingivalis/Host Interactome Shows Enrichment in GWASdb Genes Related to Alzheimer's Disease, Diabetes and Cardiovascular Diseases 2017 ·Frontiers in Aging Neuroscience ·Christopher Carter, (unknown), StJohn Crean, Sim K. Singhrao	76
3	Epstein–Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage 2011 ·Immunopharmacology and Immunotoxicology ·Christopher Carter	18
4	Alzheimer′s Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune System 2011 ·International Journal of Alzheimer s Disease ·Christopher Carter	49
5	Developmental expression of a molluscan RXR and evidence for its novel, nongenomic role in growth cone guidance 2010 ·Developmental Biology ·Christopher Carter, Nathan Farrar, Robert L. Carlone, Gaynor E. Spencer	53
6	Oxytocin, vasopressin and sociality 2008 ·Progress in brain research ·Christopher Carter, Angela J. Grippo, Hossein Pournajafi‐Nazarloo, Michael G. Ruscio, Stephen W. Porges	290
7	Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: Relevance to pathological-signalling cascades 2007 ·Neurochemistry International ·Christopher Carter	47
8	Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders? 2006 ·Behavioural Brain Research ·Christopher Carter	336
9	Discovery and development of sorafenib: a multikinase inhibitor for treating cancer breakdown → 2006 ·Nature Reviews Drug Discovery ·Scott M. Wilhelm, Christopher Carter, Mark Lynch, Timothy B. Lowinger, Jacques Dumas, Roger A. Smith, Brian Schwartz, Ronit Simantov, Susan L. Kelley	1447
10	Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis 2006 ·Neurochemistry International ·Christopher Carter	114
11	Sequence Identification and Characterization of Human Carnosinase and a Closely Related Non-specific Dipeptidase 2003 ·Journal of Biological Chemistry ·Michael Teufel, Vladimı́r Saudek, (unknown), (unknown), Sylviane Boularand, Alexandra Carreau, Nigel J. Cairns, Christopher Carter, David J. Cowley, D. Duverger, Axel J. Ganzhorn, Chantal Guénet, Blanche Heintzelmann, (unknown), (unknown), (unknown)	272
12	Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: Eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds 1996 ·Neurochemistry International ·Masahiro Nankai, Marijan Klarica, Dominique Fage, Christopher Carter	14
13	Release of spermidine from the rat cortex following permanent middle cerebral artery occlusion 1995 ·Fundamental and Clinical Pharmacology ·Christopher Carter, H. Poignet, Susanna Carboni, Dominique Fage, C. Voltz, B. Scatton	19
14	NMDA Receptors with Different Sensitivities to Magnesium and Ifenprodil Control the Release of [¹⁴C]Acetylcholine and [³H]Spermidine from Rat Striatal Slices in Vitro 1994 ·Journal of Neurochemistry ·Céline S. Nicolas, (unknown), Christopher Carter	25
15	Ornithine decarboxylase inhibition or NMDA receptor antagonism reduce cortical polyamine efflux associated with dialysis probe implantation 1993 ·Neuroscience Letters ·Dominique Fage, Susanna Carboni, C. Voltz, B. Scatton, Christopher Carter	11
16	THE NMDA MACROMOLECULAR COMPLEX AS A TARGET FOR THE DEVELOPMENT OF ANTI-ISCHEMIC DRUGS. 1992 ·Clinical Neuropharmacology ·(unknown), (unknown), Christopher Carter, H. Poignet, David Duval	1
17	Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor 1989 ·European Journal of Pharmacology ·Christopher Carter, (unknown), B. Scatton	117
18	Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease breakdown → 1989 ·Journal of Neurochemistry ·David T. Dexter, Christopher Carter, F. R. Wells, F. Javoy‐Agid, Yves Agid, Andrew J. Lees, Peter Jenner, C. D. Marsden	1142
19	Differential modulation of [3H]TCP binding to the NMDA receptor by L-glutamate and glycine 1988 ·European Journal of Pharmacology ·Jesús Bénavidès, (unknown), Christopher Carter, (unknown)	38
20	Lesions of the frontal cortex of the rat: changes in neurotransmitter systems in sub-cortical regions [proceedings]. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Christopher Carter, C Pycock	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact